McKenna Gregory J, Kim Peter T W, Mui Alice L F, Ong Christopher J, Rotstein Ori D, Warnock Garth L, Chung Stephen W
Department of Surgery, University of British Columbia, 3100-910 West 10th Avenue, Vancouver, BC, Canada, V5Z 4E3.
Am J Surg. 2006 May;191(5):588-92. doi: 10.1016/j.amjsurg.2006.02.006.
Pretransplant donor-organ immunomodulation may attenuate allograft rejection by changing the redox state of donor cells. This study explored impact of donor-cell redox-state alteration by glutathione (GSH) depletion on graft immunogenicity.
Splenic and heart endothelial cells from Balb/c mice were treated with diethylmaleate (a GSH-depleting agent) and/or lipopolysaccharide to assess the impact of GSH depletion on alloreactivity by mixed lymphocyte reaction, endothelial cell adhesion by T-cell adhesion assay, intracellular adhesion molecule-1 expression by reverse transcriptionase-polymerase chain reaction, and nuclear factor-kappa B upregulation by electrophoretic mobility shift assay. Heterotopic heart transplants were performed as in vivo correlate.
GSH depletion decreased endothelial cell and splenic cell alloreactivity, decreased endothelial cell intracellular adhesion molecule-1 expression through attenuation of nuclear factor-kappa B activity, decreased endothelial cell adhesion, and prolonged heterotopic heart transplant graft survival.
GSH depletion may represent a significant immunomodulator of donor antigenicity to prevent transplant rejection.